Response to Senn Paper (Drug Information Journal, 2001;35: 1479–1494) Stephen D. WallerGordon Guyatt Correspodence 01 January 2003 Pages: 3 - 5
What Happened to All the Patients? Event Charts for Summarizing Individual Patient Data and Displaying Clinically Significant Changes in Quality of Life Data Pamela J. AthertonBritta JaspersonJeff A. Sloan Clinical Trials 01 January 2003 Pages: 11 - 21
Practical Guidelines for Assessing the Clinical Significance of Health-Related Quality of Life Changes within Clinical Trials Jeff SloanTara SymondsBrooke Fridley Clinical Trials 01 January 2003 Pages: 23 - 31
Recruiting Strategies in the Pharmaceutical Industry Sheryl L. SzeinbachTrisha Miller Clinical Trials 01 January 2003 Pages: 33 - 38
An Overview of Recent Developments in the European Regulation of Medicine/Medical Device Combination Products David B. Jefferys Drug Regulation 01 January 2003 Pages: 39 - 43
Practical Implementation of Bayesian Dose-Escalation Procedures Yinghui ZhouJohn Whitehead Statistics 01 January 2003 Pages: 45 - 59
Generalized Lab Norms for Standardizing Data from Multiple Laboratories Francis RuvunaDavid FloresSonny Fong Statistics 01 January 2003 Pages: 61 - 79
Statistical Methodology Relevant to the Overall Drug Development Program Peter Bauer Statistics 01 January 2003 Pages: 81 - 89
An Evaluation of Weighted Chi-Square Statistics for Clustered Binary Data Chul AhnSin-Ho JungSeung-Ho Kang Statistics 01 January 2003 Pages: 91 - 99
The Statistical Basis of Laboratory Data Normalization Juha Karvanen Statistics 01 January 2003 Pages: 101 - 107
Sample Size Calculation for Dichotomous Outcomes in Cluster Randomization Trials with Varying Cluster Size Seung-Ho KongChul W. AhnSin-Ho Jung Statistics 01 January 2003 Pages: 109 - 114
A Method to Evaluate Patient Information Leaflets Jan GustafssonSofia KälvemarkJ. Lars G. Nilsson Drug Information 01 January 2003 Pages: 115 - 125
Evidence-Based Risk Management: How Can We Succeed?: Deliberations from a Risk Management Advisory Council Eleanor M. PerfettoRussell EllisonAna Maria Zaugg Drug Information 01 January 2003 Pages: 127 - 134